Published in Metabolism on March 04, 2010
Epidemiologic evidence on serum adiponectin level and lipid profile. Int J Prev Med (2013) 0.88
Apolipoprotein A-I mimetic peptide L-4F prevents myocardial and coronary dysfunction in diabetic mice. J Cell Biochem (2011) 0.84
Regional evidence of modulation of cardiac adiponectin level in dilated cardiomyopathy: pilot study in a porcine animal model. Cardiovasc Diabetol (2012) 0.78
Circulating Omentin-1 Levels Are Decreased in Dilated Cardiomyopathy Patients with Overt Heart Failure. Dis Markers (2016) 0.75
Longitudinal associations between adiponectin and cardiac structure differ by hypertensive status: Coronary Artery Risk Development in Young Adults. Cardiovasc Endocrinol (2016) 0.75
Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation (2004) 20.67
Coronary microvascular dysfunction. N Engl J Med (2007) 5.22
Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med (1995) 3.32
Adiponectin as an anti-inflammatory factor. Clin Chim Acta (2007) 2.56
Impaired myocardial metabolic reserve and substrate selection flexibility during stress in patients with idiopathic dilated cardiomyopathy. Am J Physiol Heart Circ Physiol (2007) 1.86
Cardioprotection by adiponectin. Trends Cardiovasc Med (2006) 1.86
Total and high molecular weight adiponectin, haemodynamics, and mortality in patients with chronic heart failure. Eur Heart J (2007) 1.83
Relationship of adiponectin with markers of systemic inflammation, atherogenic dyslipidemia, and heart failure in patients with coronary heart disease. Clin Chem (2006) 1.75
Hypoadiponectinemia is closely linked to endothelial dysfunction in man. J Clin Endocrinol Metab (2003) 1.75
Prognostic role of myocardial blood flow impairment in idiopathic left ventricular dysfunction. Circulation (2002) 1.66
Serum adiponectin levels in women with polycystic ovary syndrome. Hum Reprod (2003) 1.65
Low plasma adiponectin levels are associated with increased hepatic lipase activity in vivo. Diabetes Care (2005) 1.62
Serum adiponectin is a predictor of coronary heart disease: a population-based 10-year follow-up study in elderly men. J Clin Endocrinol Metab (2006) 1.61
Adiponectin protects against the development of systolic dysfunction following myocardial infarction. J Mol Cell Cardiol (2007) 1.55
Endothelium-dependent dilation of the coronary microvasculature is impaired in dilated cardiomyopathy. Circulation (1990) 1.42
Association of hypoadiponectinemia in men with early onset of coronary heart disease and multiple coronary artery stenoses. Metabolism (2006) 1.10
Myocardial blood flow response to pacing tachycardia and to dipyridamole infusion in patients with dilated cardiomyopathy without overt heart failure. A quantitative assessment by positron emission tomography. Circulation (1995) 1.10
Decreased plasma lipoprotein lipase in hypoadiponectinemia: an association independent of systemic inflammation and insulin resistance. Diabetes Care (2004) 1.08
Insulin resistance in idiopathic dilated cardiomyopathy: a possible etiologic link. J Am Coll Cardiol (2004) 1.06
Mismatch between uniform increase in cardiac glucose uptake and regional contractile dysfunction in pacing-induced heart failure. Am J Physiol Heart Circ Physiol (2007) 1.00
Association of hyperadiponectinemia with severity of ventricular dysfunction in congestive heart failure. Circ J (2006) 1.00
Determinants of myocardial blood flow response to cold pressor testing and pharmacologic vasodilation in healthy humans. Eur J Nucl Med Mol Imaging (2006) 0.97
Adiponectin levels in women with polycystic ovary syndrome. J Clin Endocrinol Metab (2003) 0.93
Inflammatory markers and serum lipids in idiopathic dilated cardiomyopathy. Am J Cardiol (2005) 0.92
Molecular mechanisms responsible for the antiinflammatory and protective effect of HDL on the endothelium. Vasc Health Risk Manag (2005) 0.88
Reduced adiponectin level is associated with severity of coronary artery disease. Int Heart J (2007) 0.87
Increase in circulating levels of adiponectin after treatment with statin and fibrate in patients with coronary artery disease and hyperlipidemia. Atherosclerosis (2006) 0.85
Does adiponectin resistance exist in chronic heart failure? Eur Heart J (2007) 0.82
Baseline plasma adiponectin levels as a predictor of left ventricular systolic dysfunction in patients referred for coronary angiography. Am J Cardiol (2008) 0.82
Coronary microvascular dysfunction and idiopathic dilated cardiomyopathy. Pharmacol Rep (2005) 0.80
A methodological reappraisal of total and high molecular weight adiponectin determination in human peripheral circulation: comparison of four immunometric assays. Clin Chem Lab Med (2010) 0.78
The role of adiponectin in atherosclerosis: do lipids tip the scales? Future Cardiol (2005) 0.77
Visceral fat in hypertension: influence on insulin resistance and beta-cell function. Hypertension (2004) 2.33
Functional lecithin: cholesterol acyltransferase is not required for efficient atheroprotection in humans. Circulation (2009) 1.56
Clinical utility of estimated glomerular filtration rate in patients undergoing gated SPECT. J Nucl Cardiol (2009) 1.40
Coronary flow reserve in severe aortic valve stenosis: a positron emission tomography study. J Cardiovasc Med (Hagerstown) (2008) 1.39
Underwater study of arterial blood pressure in breath-hold divers. J Appl Physiol (1985) (2009) 1.39
Right ventricular remodelling in systemic hypertension: a cardiac MRI study. Heart (2011) 1.39
Beneficial effect of heme oxygenase-1 expression on myocardial ischemia-reperfusion involves an increase in adiponectin in mildly diabetic rats. Am J Physiol Heart Circ Physiol (2007) 1.36
Acute effects of triiodothyronine (T3) replacement therapy in patients with chronic heart failure and low-T3 syndrome: a randomized, placebo-controlled study. J Clin Endocrinol Metab (2008) 1.26
The molecular basis of lecithin:cholesterol acyltransferase deficiency syndromes: a comprehensive study of molecular and biochemical findings in 13 unrelated Italian families. Arterioscler Thromb Vasc Biol (2005) 1.19
ABO blood group alleles: A risk factor for coronary artery disease. An angiographic study. Atherosclerosis (2010) 1.15
Does subclinical hypothyroidism affect cardiac pump performance? Evidence from a magnetic resonance imaging study. J Am Coll Cardiol (2005) 1.06
Mismatch between uniform increase in cardiac glucose uptake and regional contractile dysfunction in pacing-induced heart failure. Am J Physiol Heart Circ Physiol (2007) 1.00
Selection of reference genes for normalization of real-time PCR data in minipig heart failure model and evaluation of TNF-α mRNA expression. J Biotechnol (2011) 0.99
C-type natriuretic peptide plasma levels increase in patients with chronic heart failure as a function of clinical severity. Eur J Heart Fail (2005) 0.99
Circulating heat shock proteins and inflammatory markers in patients with idiopathic left ventricular dysfunction: their relationships with myocardial and microvascular impairment. Cell Stress Chaperones (2007) 0.96
Tangier disease: epidemiology, pathophysiology, and management. Am J Cardiovasc Drugs (2012) 0.93
Inflammatory markers and serum lipids in idiopathic dilated cardiomyopathy. Am J Cardiol (2005) 0.92
Improved myocardial perfusion in chronic diabetic mice by the up-regulation of pLKB1 and AMPK signaling. J Cell Biochem (2010) 0.92
Stress/Rest Myocardial Perfusion Abnormalities by Gated SPECT: Still the Best Predictor of Cardiac Events in Stable Ischemic Heart Disease. J Nucl Med (2009) 0.92
In vivo imaging shows abnormal function of vascular endothelial growth factor-induced vasculature. Hum Gene Ther (2007) 0.91
Chronic activation of peroxisome proliferator-activated receptor-alpha with fenofibrate prevents alterations in cardiac metabolic phenotype without changing the onset of decompensation in pacing-induced heart failure. J Pharmacol Exp Ther (2007) 0.91
Expression of C-type natriuretic peptide and of its receptor NPR-B in normal and failing heart. Peptides (2008) 0.90
Obesity-related glomerulopathy and podocyte injury: a mini review. Front Biosci (Elite Ed) (2012) 0.89
Cardiovascular risk factors and gamma-glutamyltransferase fractions in healthy individuals. Clin Chem Lab Med (2010) 0.89
Trimetazidine reduces endogenous free fatty acid oxidation and improves myocardial efficiency in obese humans. Cardiovasc Ther (2011) 0.87
Human obesity is characterized by defective fat storage and enhanced muscle fatty acid oxidation, and trimetazidine gradually counteracts these abnormalities. Am J Physiol Endocrinol Metab (2011) 0.87
Placental stem cells pre-treated with a hyaluronan mixed ester of butyric and retinoic acid to cure infarcted pig hearts: a multimodal study. Cardiovasc Res (2011) 0.87
Structural abnormalities of the coronary arterial wall--in addition to luminal narrowing--affect myocardial blood flow reserve. J Nucl Med (2011) 0.87
Tissue-specific selection of stable reference genes for real-time PCR normalization in an obese rat model. J Mol Endocrinol (2012) 0.86
Cobalt-Protoporphyrin Improves Heart Function by Blunting Oxidative Stress and Restoring NO Synthase Equilibrium in an Animal Model of Experimental Diabetes. Front Physiol (2012) 0.85
Myocardial structural, perfusion, and metabolic correlates of left bundle branch block mechanical derangement in patients with dilated cardiomyopathy: a tagged cardiac magnetic resonance and positron emission tomography study. Circ Cardiovasc Imaging (2010) 0.85
Brain glucose overexposure and lack of acute metabolic flexibility in obesity and type 2 diabetes: a PET-[18F]FDG study in Zucker and ZDF rats. J Cereb Blood Flow Metab (2010) 0.84
Individual and summed effects of high-risk genetic polymorphisms on recurrent cardiovascular events following ischemic heart disease. Atherosclerosis (2012) 0.84
Increased levels of C-type natriuretic peptide in patients with idiopathic left ventricular dysfunction. Peptides (2007) 0.84
Radioimmunoassay for plasma C-type natriuretic peptide determination: a methodological evaluation. Clin Chem Lab Med (2005) 0.84
Heme oxygenase-1 modulates fetal growth in the rat. Lab Invest (2002) 0.84
The circulating levels of cardiac natriuretic hormones in healthy adults: effects of age and sex. Clin Chem Lab Med (2002) 0.84
Early activation of an altered thyroid hormone profile in asymptomatic or mildly symptomatic idiopathic left ventricular dysfunction. J Card Fail (2006) 0.84
T(-786)→C polymorphism of the endothelial nitric oxide synthase gene is associated with insulin resistance in patients with ischemic or non ischemic cardiomyopathy. BMC Med Genet (2012) 0.83
Comparison of NT-proCNP and CNP plasma levels in heart failure, diabetes and cirrhosis patients. Regul Pept (2010) 0.83
Association of pre-operative interleukin-6 levels with Interagency Registry for Mechanically Assisted Circulatory Support profiles and intensive care unit stay in left ventricular assist device patients. J Heart Lung Transplant (2012) 0.83
Adenosine receptor mRNA expression in normal and failing minipig hearts. J Cardiovasc Pharmacol (2011) 0.82
Prognostic value of left-ventricular and peripheral vascular performance in patients with dilated cardiomyopathy. J Nucl Cardiol (2008) 0.82
Recent advances on natriuretic peptide system: new promising therapeutic targets for the treatment of heart failure. Pharmacol Res (2013) 0.82
Adenosine receptor expression in an experimental animal model of myocardial infarction with preserved left ventricular ejection fraction. Heart Vessels (2013) 0.81
Appropriateness criteria for cardiovascular imaging use in clinical practice: a position statement of the ESC/EACVI taskforce. Eur Heart J Cardiovasc Imaging (2014) 0.81
A possible cardioprotective effect of heat shock proteins during cardiac surgery in pediatric patients. Pharmacol Res (2003) 0.81
Asymmetrical myocardial expression of natriuretic peptides in pacing-induced heart failure. Peptides (2009) 0.81
Automatic PET-CT image registration method based on mutual information and genetic algorithms. ScientificWorldJournal (2012) 0.80
Osteopontin plasma levels and accelerated atherosclerosis in patients with CAD undergoing PCI: a prospective clinical study. Coron Artery Dis (2011) 0.80
Design of a RESTful web information system for drug prescription and administration. IEEE J Biomed Health Inform (2013) 0.80
Nitrogen biobank for cardiovascular research. Curr Cardiol Rev (2013) 0.80
Abnormal glucose and lipid control in non-ischemic left ventricular dysfunction. J Nucl Cardiol (2012) 0.80
Effects of long-term treatment with carvedilol on myocardial blood flow in idiopathic dilated cardiomyopathy. Heart (2007) 0.79
Surgical correction of left coronary artery origin from the right coronary artery. Ann Thorac Surg (2012) 0.79
Cardiac production of C-type natriuretic peptide in heart failure. J Cardiovasc Med (Hagerstown) (2006) 0.79
Development of a new multiplex quantitative real-time PCR assay for the detection of the mtDNA(4977) deletion in coronary artery disease patients: a link with telomere shortening. Environ Mol Mutagen (2013) 0.79
Whole-body evaluation of MIBG tissue extraction in a mouse model of long-lasting type II diabetes and its relationship with norepinephrine transport protein concentration. J Nucl Med (2008) 0.79
Severity of regional myocardial dysfunction is not affected by cardiomyocyte apoptosis in non-ischemic heart failure. Pharmacol Res (2010) 0.79
Stromal cell-derived factor-1-3'A polymorphism is associated with decreased risk of myocardial infarction and early endothelial disturbance. J Cardiovasc Med (Hagerstown) (2014) 0.78
Reduction of myocardial blood flow reserve in idiopathic dilated cardiomyopathy without overt heart failure and its relation with functional indices: an echo-Doppler and positron emission tomography study. J Cardiovasc Med (Hagerstown) (2008) 0.78
Pacing-induced regional differences in adenosine receptors mRNA expression in a swine model of dilated cardiomyopathy. PLoS One (2012) 0.78
C-type natriuretic peptide expression in patients with chronic heart failure: effects of aerobic training. Eur J Cardiovasc Prev Rehabil (2008) 0.78
Increased plasma levels of osteopontin are associated with activation of the renin-aldosterone system and with myocardial and coronary microvascular damage in dilated cardiomyopathy. Cytokine (2009) 0.78
Podocyte dysfunction in aging--related glomerulosclerosis. Front Biosci (Schol Ed) (2011) 0.78
Regional evidence of modulation of cardiac adiponectin level in dilated cardiomyopathy: pilot study in a porcine animal model. Cardiovasc Diabetol (2012) 0.78
The role of the adenosinergic system in lung fibrosis. Pharmacol Res (2013) 0.78
Womersley number-based estimation of flow rate with Doppler ultrasound: sensitivity analysis and first clinical application. Comput Methods Programs Biomed (2009) 0.78
Adiponectin plasma levels decrease after surgery in pediatric patients with congenital heart disease. Clin Biochem (2012) 0.78
Nitric oxide treatment reduces neo-intimal formation and modulates osteopontin expression in an ex-vivo human model of intimal hyperplasia. Cytokine (2009) 0.78
A methodological reappraisal of total and high molecular weight adiponectin determination in human peripheral circulation: comparison of four immunometric assays. Clin Chem Lab Med (2010) 0.78
Routine laboratory tests to risk-stratify patients with chronic coronary artery disease. J Cardiol (2012) 0.78